Regulation FD Presentation (Form 8-K)

HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K

Company believes proposed Fortitude merger represents a significant opportunity for the Company's shareholders; preliminary proxy statement in connection with the Proposed Transaction expected to be filed shortly, with fiscal 2026 earnings release and business update to follow

Southlake, TX, July 23, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing electrocardiography ("ECG" or "EKG") through the integration of artificial intelligence ("AI"), today announced that it has filed its Annual Report on Form 10-K (the "Form 10-K") for the fiscal year ended April 30, 2026 ("fiscal 2026") with the U.S. Securities and Exchange Commission (the "SEC"). The Form 10-K is available at www.sec.gov and on the Company's website at www.heartsciences.com.

The Company also expects to file shortly with the SEC a preliminary proxy statement in connection with its recently announced proposed business combination and related transactions (the "Proposed Transaction") with Fortitude Mining Holdings, Inc. ("Fortitude"), an institutional-scale, vertically integrated venture mining platform operating across the Proof-of-Work ecosystem and anchored in Zcash, currently wholly-owned by Digital Currency Group ("DCG"). The Company believes the Proposed Transaction represents a significant opportunity for its shareholders, providing continued ownership in a business operating at scale, generating meaningful revenue and backed by an established investor, while enabling the Company's MyoVista Insights AI-ECG technology to keep advancing with greater focus.

Following the filing of the preliminary proxy statement, the Company intends to issue its fiscal 2026 earnings release and a business update, currently expected early next week.

"Fiscal 2026 was a landmark year for HeartSciences, with the launch of MyoVista Insights and the beginning of our transition to mainstream commercial revenue," said Andrew Simpson, the CEO of HeartSciences. "We also believe the proposed business combination with Fortitude represents a significant value creation opportunity for our shareholders. The proxy statement will set out the transaction in detail, and we look forward to discussing our results, the proposed merger and the path ahead in our full earnings statement and business update early next week."

For more information, please visit: https://www.heartsciences.com. X: @HeartSciences

About Fortitude

Fortitude, currently wholly-owned by DCG, is an institutional-scale, vertically integrated venture mining platform operating across the Proof-of-Work ecosystem and anchored in Zcash. Fortitude pairs self-mining operations with an owned data center footprint, a diversified power portfolio backed by competitive long-term contracts, and disciplined capital allocation to identify and scale high-conviction opportunities in emerging Proof-of-Work ecosystems, beginning with its meaningful position in the Zcash network. Fortitude is led by an experienced team of operators, capital markets professionals, and digital asset specialists with a track record of identifying and scaling high-conviction opportunities and building privacy-preserving digital asset infrastructure.

For more information, visit www.fortitudemining.com and follow Fortitude on X at @FortitudeCrypto

About HeartSciences

HeartSciences is a healthcare information technology company advancing the use of ECG/EKGs through the integration of artificial intelligence. HeartSciences' MyoVista Insights™ Platform is a device-agnostic, next-generation ECG management system designed to improve clinical efficiency and decision-making. Its MyoVista wavECG device is designed to deliver conventional ECG functionality while supporting on-device AI-enabled solutions.

For more information, please visit: www.heartsciences.com and follow HeartSciences on X at @HeartSciences